/
MIR
$17.46-$0.99 (-5.37%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.5B
245M shares
52-week range
$15.58 – $30.28
13% from low
Sector
MEASURING & CONTROLLING DEVICES, NEC
Exchange
NYSE
CS
Borrow rate
0.27%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$6.58
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $444.1M | $440.1M | $0 | $668.3M | $717.8M | $800.9M | $860.8M | $925.4M |
| Cost of revenue | $275.7M | $251.8M | $0 | $384.1M | $400.6M | $444.4M | $459.0M | $486.8M |
| Gross profit | $168.4M | $188.3M | $0 | $284.2M | $317.2M | $356.5M | $401.8M | $438.6M |
| Gross margin | 37.9% | 42.8% | — | 42.5% | 44.2% | 44.5% | 46.7% | 47.4% |
| R&D | $19.3M | $14.0M | $0 | $36.2M | $30.3M | $31.7M | $35.0M | $38.9M |
| Operating income | −$4.7M | $28.8M | −$2.4M | −$68.7M | −$297.8M | −$21.9M | $24.8M | $51.5M |
| EBITDA | $72.3M | $98.4M | $68.6M | $92.6M | $104.3M | $149.0M | $179.0M | $212.9M |
| Net income | −$103.7M | −$122.0M | −$45.3M | −$222.5M | −$276.9M | −$96.9M | −$36.1M | $28.8M |
| Net margin | -23.4% | -27.7% | — | -33.3% | -38.6% | -12.1% | -4.2% | 3.1% |
| EPS (diluted) | -0.00 | 0.00 | -0.48 | -0.61 | -1.53 | -0.49 | -0.18 | 0.11 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.1B | $0.54 | $0.51–$0.56 | 5 |
| 2027 | $1.2B | $0.65 | $0.59–$0.73 | 4 |
| 2028 | $1.3B | $0.81 | $0.80–$0.82 | 3 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$21.15
Price
$17.46
Implied upside
+21%
Peer comparison
Mirion Technologies, Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
www.mirion.com- Employees
- 3,281
- IPO / List date
- Aug 20, 2020
- HQ
- ATLANTA, GA
Held by traders on TradeandTell
No one on the platform currently holds MIR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 351,785 | $6.5M |
| Renaissance Technologiesas of 2025-06-30 | 115,900 | $2.5M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MIR yet.
